Fa­heem Has­nain is go­ing back to run­ning a biotech start­up. And he has his work cut out for him

Af­ter found­ing Gos­samer Bio $GOSS and hand­ing the CEO’s reins to his long­time col­league and co-founder Sheila Gu­jrathi, biotech en­tre­pre­neur Fa­heem Has­nain is step­ping back in to run the com­pa­ny at a crit­i­cal junc­ture.

Mon­day morn­ing Gos­samer re­port­ed that Has­nain has been re-ap­point­ed CEO of Gos­samer, weeks af­ter their lead drug failed 2 key mid-stage tri­als. Now it will be up to Has­nain to work through talks with the FDA to see if there’s a path for­ward for the drug in­to a Phase III asth­ma study — and a part­ner out there in the in­dus­try who would like to car­ry this for­ward.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER